ReviewAdvances in virology2013
Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus.
Review in Advances in virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 57 citations in OpenAlex.
- Epidemiological Changes in Pediatric RSV Infections in Poland (2016-2024): Impact of the COVID-19 Pandemic.Journal of clinical medicine · 2025Article
- Systematic collection, annotation, and pattern analysis of viral vaccines in the VIOLIN vaccine knowledgebase.Frontiers in cellular and infection microbiology · 2025Article
- Fatal Deterioration of a Respiratory Syncytial Virus Infection in an Infant with Abnormal Muscularization of Intra-Acinar Pulmonary Arteries: Autopsy and Histological Findings.Diagnostics (Basel, Switzerland) · 2024Article
- Reclassification of respiratory syncytial virus genotypes in India.Virusdisease · 2023Article
- The presence of human respiratory syncytial virus in the cerebrospinal fluid of a child with Anti-N-methyl-D-aspartate receptor encephalitis of unknown trigger.Virology journal · 2023Article
- Review
- Age-Specific Etiology of Severe Acute Respiratory Infections and Influenza Vaccine Effectivity in Prevention of Hospitalization in Russia, 2018-2019 Season.Journal of epidemiology and global health · 2021Article
- Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines.Pharmaceuticals (Basel, Switzerland) · 2021Review
- Nanomaterials-Based Sensors for Respiratory Viral Detection: A Review.IEEE sensors journal · 2021Article
- Article
- Viral Etiology of Acute Respiratory Infections in Pediatric Patients in Lebanon.Mediterranean journal of hematology and infectious diseases · 2019Article
- Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus.Bioengineering (Basel, Switzerland) · 2018Article
- Multicenter Clinical Evaluation of the Alere i Respiratory Syncytial Virus Isothermal Nucleic Acid Amplification Assay.Journal of clinical microbiology · 2018Article
- Digital Image Analysis of Cells and Computational Tools for the Study of Mechanism of RSV Entry to Human Bronchial Epithelium.Sistemas e Tecnologias de Informacao : atas de 12a Conferencia Iberica de Sistemas e Tecnologias de Informacao (CISTI'2017) : 21 a 24 de junho de 2017, Lisboa, Portugal = Information systems and technologies : proceedings of the 12th Ib... · 2017Article
- Influence of meteorological conditions on RSV infection in Portugal.International journal of biometeorology · 2016Article
- Gold nanorods inhibit respiratory syncytial virus by stimulating the innate immune response.Nanomedicine : nanotechnology, biology, and medicine · 2016Article
- Facile and rapid detection of respiratory syncytial virus using metallic nanoparticles.Journal of nanobiotechnology · 2016Article
- Application of Traditional Chinese Medical Herbs in Prevention and Treatment of Respiratory Syncytial Virus.Evidence-based complementary and alternative medicine : eCAM · 2016Review
- Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials.Influenza and other respiratory viruses · 2015Review
- MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice.Respiratory research · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
Abstract
Human respiratory syncytial virus (RSV) is a common cause of respiratory infection in infants and the elderly, leading to significant morbidity and mortality. The interdisciplinary fields, especially biotechnology and nanotechnology, have facilitated the development of modern detection systems for RSV. Many anti-RSV compounds like fusion inhibitors and RNAi molecules have been successful in laboratory and clinical trials. But, currently, there are no effective drugs for RSV infection even after decades of research. Effective diagnosis can result in effective treatment, but the progress in both of these facets must be concurrent. The development in prevention and treatment measures for RSV is at appreciable pace, but the implementation into clinical practice still seems a challenge. This review attempts to present the promising diverse research approaches and advancements in the area of diagnosis, prevention, and treatment that contribute to RSV management.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.